A new blood test for colon cancer just got approved by the FDA

Category: Health

The FDA has approved Guardant Health's Shield test, a new blood test for colorectal cancer screening in adults over 45, marking it as the first blood test to be recognized as a primary screening option for CRC. The test detects cancer signals from DNA in the bloodstream, showing 83% sensitivity for colorectal cancers. While not as effective as colonoscopies, it offers a less invasive alternative for those hesitant about traditional screenings.

Keywords: Colorectal Cancer, Blood Test, FDA Approval

Source: Quartz

Update At: 7/30/2024

Related Sources